Research SummaryKey Findings

What research findings does TB500(Thymosin B4 Acetate) have regarding wound and soft tissue repair?

Improves wound healing in mice and explores immune-related effects involving Vsig4 and IL22rα2.[1] ↗

Before ReadingStudy populations, species, formulations and delivery conditions each have a defined scope. Research on an ingredient does not establish that this site's product batches have been validated for efficacy in humans or veterinary use.
i

Currently Selected 1 Original Study Related to the Theme of This Page. Fewer than 3 studies, the gap is retained, no other uses are added to fill the number. This page is a purposive collection of positive information, not a systematic review or dosage recommendation. Historical studies, combination formulations, and special models are separately indicated.

Comparison of study design and results

Results from different populations, species, materials, or follow-up times cannot be directly combined. The table below is a comparative summary of published data, not new experimental data.

LiteratureStudy subjects and designObservation and discoveryScope of Explanation
2026 · PMID 41467542Whole Tβ4-loaded soluble microneedles; Mouse skin wounds and cellsImproves wound healing in mice and explores immune-related effects involving Vsig4 and IL22rα2.Microneedle delivery, full Tβ4 differs from ordinary TB500 heptapeptide; the product sequence must be confirmed first, it does not indicate clinical efficacy in humans.

References

Animal / experimental studies2026REF. 01

How does complete Tβ4 microneedling study wound repair?

Research Findings

Improves wound healing in mice and explores immune-related effects involving Vsig4 and IL22rα2.[1] ↗

Study Design

Whole Tβ4-loaded soluble microneedles; Mouse skin wounds and cells

Scope & Limitations

Microneedle delivery, full Tβ4 differs from ordinary TB500 heptapeptide; the product sequence must be confirmed first, it does not indicate clinical efficacy in humans.

View the Article Title and Full Citation+

Low-Temperature Fabrication of Thymosin β4-Loaded Soluble Microneedles to Promote Wound Healing by Specific Binding to Downregulated Immune Regulators Vsig4 and IL22rɑ2.

He S, Yuan M, Feng C, Zhang Y, Che J

Advanced Healthcare Materials · Volume/Issue, 2026
First published 2025-12-30 · PMID 41467542
DOI 10.1002/adhm.202504878

Common issues and corresponding evidence

What research findings does TB500(Thymosin B4 Acetate) have regarding wound and soft tissue repair?+

Improves wound healing in mice and explores immune-related effects involving Vsig4 and IL22rα2.[1] ↗

Are there papers where TB500 can directly use full Tβ4?+

Sequence and molecular weight must be verified first. When TB500 and Thymosin B4 appear simultaneously in the product name, the full Tβ4 microneedle study cannot be directly applied to the heptapeptide or other fragments based on the name alone.[1] ↗

TB500(Thymosin B4 Acetate)—these conclusions apply to which study populations?+

Complete Tβ4 loaded with soluble microneedles; Mouse skin wounds and cells. Microneedle delivery and complete Tβ4 differ from ordinary TB500 heptapeptide; Prior confirmation of product sequence is required; does not represent clinical efficacy in humans.[1] ↗

TB500(Thymosin B4 Acetate)

Return to catalog specifications and batch file verification entry.

↗